[1]
|
American Cancer Society, “Cancer Facts & Figures 2009,” American Cancer Society, Atlanta, 2009.
|
[2]
|
D. E. James, R. Brown, J. Navarro and P. R. Pilch, “Insulin Regulatable Tissues Express a Unique Insulin-Sensitive Glucose Transport Protein,” Nature, Vol. 333, 1988, pp. 183-185.
|
[3]
|
D. E. James, M. Strube and M. Mueckler, “Molecular Cloning and Characterization of an Insulin Regulatable Glucose Transporter,” Nature, Vol. 338, 1989, pp. 83-87.
doi:10.1038/338083a0
|
[4]
|
M. H. Ross and E. J. Reith. “Epithelium,” Histology, New York, 1985.
|
[5]
|
C. B. Begg, “Methodological and Statistical Considerations in the Study of Multiple Primary Cancers,” Multiple Primary Cancers, PA: Lippincott Williams and Wilkins, Philadelphia, 1999, pp. 13-26.
|
[6]
|
R. Marx, D. Stern. “Premalignant and malignant epithelial tumors of mucosa and skin”. In: Oral and Maxillofacial Pathology. Quintaesscence, First edition, 2003; 283 -373
|
[7]
|
F. R. Miller, D. Hussey, M. Beeram, T. Eng, H. S. Mc- Guff and A. O.Randall, “Positron Emission Tomography in the Management of Unknown Primary Head and Neck Carcinoma,” Archives of Otolaryngology Head and neck Surgery, Vol. 131, No. 7, 2005, pp. 626-629.
doi:10.1001/archotol.131.7.626
|
[8]
|
H. Schoder, H. W. D. Yeung, M. Gonen, D. Krauss and S. M. Larson, “Positron Emission Imaging of Head and Neck Cancer, Including Thyroid Carcinoma,” Seminars in Nuclear Medicine, Vol. 34, No. 3, 2004, pp. 180-197.
doi:10.1053/j.semnuclmed.2004.03.004
|
[9]
|
A. F. Kovacs, N. Dobert and J. Gaa, “Positron Emission Tomography in Combination with Sentinel Lymph Node biopsy Reduces the Rate of Elective Neck Dissections in the Treatment of Oral and Oropharyngeal Cancer,” Journal of Clinical Oncology, Vol. 22, No. 19, 2004, pp. 3973-3980. doi:10.1200/JCO.2004.01.124
|
[10]
|
D. L. Schwartz, E. Ford, J. Rajendran, B. Yueh, M. D. Coltrera and F. Virgin, et al. “FDG-PET/CT Imaging for Preradiotherapy Staging of Head and Neck Squamous Cell Carcinoma,” International Journal of Radiation Oncology Biology and Physics, Vol. 61, No. 1, 2005, pp. 129- 136. doi:10.1016/j.ijrobp.2004.03.040
|
[11]
|
W. J. Wong and M. Saunders, “The Impact of FDG PET on the Management of Occult Primary Head and Neck Tumors,” Clinical Oncology, Vol. 15, No. 8, 2003, pp. 461-466. doi:10.1016/j.clon.2003.07.006
|
[12]
|
Y. Menda and M. Graham, “Update on FDG / PET and Positron Emission Tomography/Computed Tomography Imaging of Squamous Head and Neck Cancers,” Seminars in Nuclear Medicine, Vol. 35, No. 4, 2005, pp. 214-219. doi:10.1053/j.semnuclmed.2005.05.001
|
[13]
|
L. Kostakoglu, “FDG-PET Evaluation of Response to Treatment,” PET Clinics, Vol. 3, No. 1, 2008, pp. 37-75.
doi:10.1016/j.cpet.2008.09.001
|
[14]
|
G. W. Goerres, D. T. Schimdt and F. Bandhauer, “Positron Emission Tomography in the Early Follow Up of Advanced Head and Neck Cancer,” Archives of Otolaryngology Head and Neck Surgery, Vol. 130, No. 1, 2004, pp. 105-109. doi:10.1001/archotol.130.1.105
|